Hypertrophic obstructive cardiomyopathy-left ventricular outflow tract shapes and their hemodynamic influences

T Mayr1,2, L Riazy1,2,3, R F Trauzeddel1,2,4

  • 1ECRC Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Lindenberger Weg 80, 13125, Berlin, Germany.

Insights

Cardiovascular magnetic resonance identified three distinct shapes of left ventricular outflow tract (LVOT) obstruction in hypertrophic cardiomyopathy patients. These anatomical variations significantly impact blood flow dynamics and may influence treatment strategies.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Fluid Dynamics

Background:

  • Hypertrophic cardiomyopathy (HCM) is a common genetic heart disorder.
  • Left ventricular outflow tract (LVOT) obstruction is a key phenotype in HCM.
  • LVOT obstruction's anatomical variations can affect hemodynamics and treatment decisions.

Purpose of the Study:

  • To identify distinct anatomical shapes of LVOT obstruction in HCM using cardiovascular magnetic resonance (CMR).
  • To assess the hemodynamic consequences of these identified LVOT obstruction shapes.

Main Methods:

  • In-vivo analysis: 3D LVOT reconstruction from 2D CMR slices in 125 HCM patients.
  • In-vitro analysis: 2D and 4D flow measurements on 3D printed phantoms based on in-vivo anatomy.
  • Patient cohort: 125 consecutive HCM patients (mean age 64.17 years, 42 female).

Main Results:

  • Three primary LVOT obstruction shapes identified: K-shape (28.8%), X-shape (51.2%), V-shape (10.4%), and a mixed shape (9.6%).
  • Each shape exhibited unique hemodynamic profiles and maximum velocities.
  • V-shape demonstrated the highest velocity (138.87 cm/s), followed by K-shape (137.11 cm/s) and X-shape (125.39 cm/s).

Conclusions:

  • This study is the first to identify and categorize distinct anatomical shapes of LVOT obstruction in HCM.
  • These identified shapes (K, X, V) appear to influence the hemodynamic characteristics of HCM.
  • Further research into these variants may refine therapeutic decision-making for HCM patients.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460